Answers are grounded in this paper and cite their sources.
When incubated with BSA-rabbit anti-BSA precipitates, human PMN-leuko-cytes release β-glucuronidase, neutral protease and an enzyme which Iiberates kinin from highly purified kininogen. The release of β-glucuronidase and of the kinin-generating enzyme is enhanced when the immune precipitates are incubated with the cells in the presence of cytochalasin B. The leukocytes do not release lactic dehydrogenase, indicating good viability. When the PMN-leukocytes are fractionatedpost of the hydrolase and kinin-forming activity is recovered in the granule (lysosomal) fraction.Liberation of kinin from kininogen is a rapid process; its rate depends on the concentration of enzyme in the reaction mixture, whereas the amount of kinin generated is a function of kininogen concentration. Kinin-forming activity is highly heat-labile, susceptible to DFP and to a1-antitrypsin.The liberated kinin is retained by UM-2 ultrafilters, indicating a molecular weight larger than 1,000. By gel filtration on Sephadex G-50 it was not possible to discriminate between the elution volume of synthetic bradykinin (MW 1,060), of vitamin B12 (MW 1,360) and that of the kinin generated by leukocyte lysosomal protease.
No takes yet. Share an insight, caveat, or question.
Movat et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: